Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Other Non-Current Liabilities (2018 - 2026)

Health Catalyst filings provide 9 years of Other Non-Current Liabilities readings, the most recent being $250000.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 96.58% to $250000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $250000.0, a 96.58% decrease, with the full-year FY2025 number at $798000.0, up 418.18% from a year prior.
  • Other Non-Current Liabilities hit $250000.0 in Q1 2026 for Health Catalyst, down from $798000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $7.3 million in Q1 2025 to a low of $40000.0 in Q3 2025.
  • Median Other Non-Current Liabilities over the past 5 years was $119500.0 (2022), compared with a mean of $808875.0.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 99.18% in 2022 and later soared 8210.23% in 2025.
  • Health Catalyst's Other Non-Current Liabilities stood at $121000.0 in 2022, then tumbled by 38.84% to $74000.0 in 2023, then surged by 108.11% to $154000.0 in 2024, then skyrocketed by 418.18% to $798000.0 in 2025, then crashed by 68.67% to $250000.0 in 2026.
  • The last three reported values for Other Non-Current Liabilities were $250000.0 (Q1 2026), $798000.0 (Q4 2025), and $40000.0 (Q3 2025) per Business Quant data.